Bas Heinhuis
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Mimicking Behçet's disease: GM-CSF gain of function mutation in a family suffering from a Behçet's disease-like disorder marked by extreme pathergy.
Journal: Clinical and experimental immunology
Published: September 01, 2019
Interplay between thyroid cancer cells and macrophages: effects on IL-32 mediated cell death and thyroid cancer cell migration.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: May 17, 2019
Interleukin-32 upregulates the expression of ABCA1 and ABCG1 resulting in reduced intracellular lipid concentrations in primary human hepatocytes.
Journal: Atherosclerosis
Published: September 23, 2017
The NOD2 receptor is crucial for immune responses towards New World Leishmania species.
Journal: Scientific reports
Published: August 29, 2017
Exploring the Role of IL-32 in HIV-Related Kaposi Sarcoma.
Journal: The American journal of pathology
Published: March 23, 2017
Cytokines and microbicidal molecules regulated by IL-32 in THP-1-derived human macrophages infected with New World Leishmania species.
Journal: PLoS neglected tropical diseases
Published: October 21, 2016
IL-32 promoter SNP rs4786370 predisposes to modified lipoprotein profiles in patients with rheumatoid arthritis.
Journal: Scientific reports
Published: September 14, 2016
Transcriptional and metabolic reprogramming induce an inflammatory phenotype in non-medullary thyroid carcinoma-induced macrophages.
Journal: Oncoimmunology
Published: August 01, 2016
mTOR Inhibition promotes TTF1-dependent redifferentiation and restores iodine uptake in thyroid carcinoma cell lines.
Journal: The Journal of clinical endocrinology and metabolism
Published: April 10, 2014
IL-32 promotes angiogenesis.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: December 17, 2013
Last Updated: 09/26/2026